Imisopasem Manganese

N/A

Report date: 2022/11/25 17:57:34
NME

Base Information

Drug NameImisopasem Manganese
Drug Alias Nameimisopasem manganeso伊米帕锰imisopasemum manganumSuperoxide dismutase mimic - MetaPhoreGC-4403 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSuperoxide dismutase stimulants
TargetsSuperoxide dismutase
Therapy Area/IndicationsPainHypotensionNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMetaphore Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMetaphore Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsPainHypotensionNeoplasms

Other Information

ATC CodeN/A
Related LinksKEGG